NICE Advice: system engagement service for market access planning

Learn how NICE Advice’s system engagement service helps life sciences companies spot NHS adoption barriers before they become roadblocks. Senior adviser for NICE Advice You’ve developed an innovative medicine, device, diagnostic or digital technology. Your evidence is strong. But strong evidence alone does not guarantee routine NHS patient access.Where does your product sit in the treatment pathway?  How might potential uncertainties in your evidence base be viewed by a NICE committee? What does the NHS need in order to adopt your product into routine care?  These connected questions often sit between product development, health technology assessment and NHS adoption. They are not always easy questions to answer from published information